Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and Acute Disease

olmesartan has been researched along with Acute Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Araki, R; Hamamoto, T; Minami, C; Yamada, H1
Bi, X; Shan, L; Wang, S; Zhou, Y1
Seko, Y1
Fischer, JW; Fritzenkötter, C; Li, J; Sandmann, S; Spormann, J; Tiede, K; Unger, T1

Other Studies

4 other study(ies) available for olmesartan and Acute Disease

ArticleYear
[Orolingual Angioedema after Recombinant Tissue Plasminogen Activator Treatment in Acute Cardiogenic Cerebral Embolism Patient Using Olmesartan: A Case Report].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:1

    Topics: Acute Disease; Aged, 80 and over; Angioedema; Angiotensin II Type 1 Receptor Blockers; Cerebral Infarction; Humans; Imidazoles; Intracranial Embolism; Male; Recombinant Proteins; Tetrazoles; Tissue Plasminogen Activator

2022
Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2014, Volume: 112, Issue:2

    Topics: Acute Disease; Aged, 80 and over; Angioedema; Antihypertensive Agents; Female; Humans; Imidazoles; Lip; Methylprednisolone; Recombinant Proteins; Stroke; Tetrazoles; Tissue Plasminogen Activator; Tongue; Uvula

2014
Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3.
    Clinical science (London, England : 1979), 2006, Volume: 110, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cytokines; Deoxyguanosine; Drug Evaluation, Preclinical; Enterovirus B, Human; Enterovirus Infections; Genome, Viral; Heart Rate; Hydralazine; Imidazoles; Inflammation Mediators; Lymphocyte Activation; Male; Mice; Mice, Inbred C3H; Myocarditis; Tetrazoles; Vasodilator Agents

2006
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Blood pressure, 2006, Volume: 15, Issue:2

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Inflammation; Interleukin-1; Interleukin-6; Male; Myocardial Infarction; Placebos; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha

2006